Woodline Partners LP

Position in FBRX — Forte Biosciences, Inc.

CIK 1784547 San Francisco, CA

Position in FBRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$15,146,001

+$6,547,538 QoQ

Shares Held

712,753

+114.7% QoQ

Ownership

3.36%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#10

of 85 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. FBRX ranks #76 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,002,863	$375,096,182
2	PTGX	Protagonist Therapeutics, Inc	1,414,173	$173,349,326
3	TNGX	Tango Therapeutics, Inc.	4,000,567	$125,057,724
4	BHVN	Biohaven Ltd.	7,660,280	$113,984,966
5	COGT	Cogent Biosciences, Inc.	2,603,162	$100,742,369
6	CYTK	Cytokinetics Inc	1,100,708	$93,769,314
7	RCUS	Arcus Biosciences, Inc.	3,007,798	$92,730,412
8	ROIV	Roivant Sciences Ltd.	2,500,673	$88,498,817

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,146,001	712,753	+114.7%	Shares	Sole	2026-08-14
2026-03-31	$8,598,463	331,987	0.0%	Shares	Sole	2026-05-15
2025-12-31	$9,053,285	331,987	0.0%	Shares	Sole	2026-02-17
2025-09-30	$4,979,805	331,987	0.0%	Shares	Sole	2025-11-14
2025-06-30	$4,292,591	331,987	+62.1%	Shares	Sole	2025-08-14
2025-03-31	$1,589,418	204,822	+0.3%	Shares	Sole	2025-05-15
2024-12-31	$4,639,085	204,275	+42.7%	Shares	Sole	2025-02-14
2021-09-30	$423,584	143,103	-26.1%	Shares	Sole	2021-11-15
2021-06-30	$6,510,950	193,663	+1.8%	Shares	Sole	2021-08-16
2021-03-31	$6,522,095	190,315	-1.0%	Shares	Sole	2021-05-17
2020-12-31	$7,000,405	192,266	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.